0001213900-25-031562.txt : 20250414 0001213900-25-031562.hdr.sgml : 20250414 20250414160123 ACCESSION NUMBER: 0001213900-25-031562 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250414 DATE AS OF CHANGE: 20250414 EFFECTIVENESS DATE: 20250414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NLS Pharmaceutics Ltd. CENTRAL INDEX KEY: 0001783036 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-543658 FILM NUMBER: 25835989 BUSINESS ADDRESS: STREET 1: THE CIRCLE 6 STREET 2: 8058 CITY: ZURICH STATE: V8 ZIP: CH-6370 BUSINESS PHONE: 41-41-618-80-00 MAIL ADDRESS: STREET 1: THE CIRCLE 6 STREET 2: 8058 CITY: ZURICH STATE: V8 ZIP: CH-6370 D 1 primary_doc.xml X0708 D LIVE 0001783036 NLS Pharmaceutics Ltd. THE CIRCLE 6 ZURICH V8 SWITZERLAND 8058 +41.44.512.2150 SWITZERLAND None None Other Limited Company true Alexander Zwyer The Circle 6 Zurich V8 SWITZERLAND 8058 Executive Officer Director Chief Executive Officer Ronald Hafner The Circle 6 Zurich V8 SWITZERLAND 8058 Director Chairman of the Board of Directors Nicole Fernandez-McGovern The Circle 6 Zurich V8 SWITZERLAND 8058 Executive Officer Chief Financial Officer and Chief Operating Officer Florence Allouche Aknin The Circle 6 Zurich V8 SWITZERLAND 8058 Director Gian-Marco Rinaldi de la Cruz The Circle 6 Zurich V8 SWITZERLAND 8058 Director Audrey Greenberg The Circle 6 Zurich V8 SWITZERLAND 8058 Director Olivier Samuel The Circle 6 Zurich V8 SWITZERLAND 8058 Director Pharmaceuticals Decline to Disclose 06b false 2025-03-28 false true false 0 2000000 2000000 0 Represents total gross proceeds received by the company in connection with a private placement of preferred shares and warrants. false 3 0 0 0 false NLS Pharmaceutics Ltd. /s/ Alexander Zwyer Alexander Zwyer Chief Executive Officer 2025-04-14